GlaxoSmithKline has continued its expansion into China with the $70 million acquisition of a local firm. Nanjing MeiRui Pharma Co’s …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

